{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:45:29Z","timestamp":1791888329333,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cervical cancer is the second cause leading of malignancy-related death among Mexican women. The present study determined the population-based prevalence of high risk Human Papillomavirus (HR-HPV) infection and associated cofactors in female beneficiaries of the Institute of Security and Social Services for State Workers (ISSSTE) attending the Program for HPV Screening and Early Detection of Cervical Cancer and registered in the Women\u2019s Cancer Detection System (SIDECAM).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In a cross-sectional study, cervical samples from 115,651 female users of the program for HPV screening and early detection of cervical cancer recruited in 23 ISSSTE care centers were analyzed for HR-HPV. Logistic regression analyses, adjusting for potential confounders, were performed to determine the association of HR-HPV infection with sexual health and behavior variables and with positivity to cervical premalignant lesions by cytology.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The overall prevalence of HR-HPV infection among female ISSSTE beneficiaries in the 2013\u20132015 period was 13%. A bivariate analysis of relevant variables for HR-HPV infection showed a statistically significant association for age, number of sexual partners, use of hormonal contraceptives and smoking. A statistical association was found between infection by HR-HPV with the use of hormonal contraceptives, number of sexual partners and smoking and association of HPV 16 and other non-16\/18 HR-HPV infection with number of lifetime sexual partners and tobacco use adjusted for age, history of hormonal contraception, number of sexual partners and tobacco use with the exception of exposition variable itself. Similarly, an association was found between HR-HPV infection, regardless of the virus genotype, with positivity to cervical premalignant lesions adjusted for age, number of lifetime sexual partners, history of hormonal contraception and tobacco use.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>HR-HPV prevalence in female ISSSTE Women\u2019s Cancer Program users is similar to the population-based prevalence previously reported in Mexican women without cervical alterations. The ISSSTE robust screening and early detection program, based on cytology studies and HPV co-testing, allows us to know the prevalence of HR-HPV infection among female users of the service.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-019-6388-4","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T16:04:55Z","timestamp":1575993895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program"],"prefix":"10.1186","volume":"19","author":[{"given":"K.","family":"Torres-Poveda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ruiz-Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Madrid-Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"9","key":"6388_CR1","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609\u201316.","journal-title":"Lancet Glob Health"},{"key":"6388_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.21149\/spm.v58i2.7780","volume":"58","author":"H G\u00f3mez-Dant\u00e9s","year":"2016","unstructured":"G\u00f3mez-Dant\u00e9s H, Lamadrid-Figueroa H, Cahuana-Hurtado L, et al. La carga del c\u00e1ncer en M\u00e9xico, 1990-2013. Salud Publica Mex. 2016;58:118\u201331.","journal-title":"Salud Publica Mex"},{"issue":"Suppl 5","key":"6388_CR3","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12\u201323.","journal-title":"Vaccine"},{"issue":"12","key":"6388_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"key":"6388_CR5","unstructured":"Secretar\u00eda de Salud. Modificaci\u00f3n a la Norma Oficial Mexicana NOM-014-SSA2\u20131994, Para la prevenci\u00f3n, detecci\u00f3n, diagn\u00f3stico, tratamiento, control y vigilancia epidemiol\u00f3gica del c\u00e1ncer c\u00e9rvico uterino. Available from: http:\/\/www.salud.gob.mx\/unidades\/cdi\/nom\/m014ssa294.pdf"},{"key":"6388_CR6","unstructured":"Secretar\u00eda de Salud. Programa de Acci\u00f3n: c\u00e1ncer c\u00e9rvico uterino. 2002 Programa de Acci\u00f3n Espec\u00edfico Prevenci\u00f3n y Control del C\u00e1ncer de la Mujer 2013\u20132018. Available from: https:\/\/www.gob.mx\/salud\/acciones-y-programas\/programa-de-accion-especifico-prevencion-y-control-del-cancer-de-la-mujer-2013-2018-9275."},{"key":"6388_CR7","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/JCM.00337-12","volume":"50","author":"Y Park","year":"2012","unstructured":"Park Y, Lee E, Choi J, Jeong S, Kim HS. Comparison of the Abbott RealTime high-risk human papillomavirus (HPV), roche cobas HPV, and hybrid capture 2 assays to direct sequencing and genotyping of HPV DNA. J Clin Microbiol. 2012;50:2359\u201365.","journal-title":"J Clin Microbiol"},{"key":"6388_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12879-016-1782-x","volume":"16","author":"SE Rudolph","year":"2016","unstructured":"Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, Le\u00f3n-Maldonado L, Ram\u00edrez P, Rivera B, Hern\u00e1ndez R, Franco EL, Cuzick J, M\u00e9ndez-Hern\u00e1ndez P, Salmer\u00f3n J, FRIDA Study Group. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala. Mexico BMC Infect Dis. 2016;16:461.","journal-title":"Mexico BMC Infect Dis"},{"key":"6388_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M","volume":"91","author":"E Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce E, Herrero R, Mu\u00f1oz N, Cruz A, Shar KV, Alonso P, Hernandez P, Salmer\u00f3n J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412\u201320.","journal-title":"Int J Cancer"},{"key":"6388_CR10","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1086\/428850","volume":"191","author":"R Herrero","year":"2005","unstructured":"Herrero R, Castle PE, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1796\u2013807.","journal-title":"J Infect Dis"},{"key":"6388_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","volume":"87","author":"M Molano","year":"2002","unstructured":"Molano M, Posso H, Weiderpass E, van den Brule AJC, Ronderos M, Franceschi S, Meijer CJLM, Arslan A, Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324\u201333.","journal-title":"Br J Cancer"},{"key":"6388_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: MetahAnalysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789\u201399.","journal-title":"J Infect Dis"},{"key":"6388_CR13","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ijc.22241","volume":"119","author":"S Franceschi","year":"2006","unstructured":"Franceschi S, Herrero R, Clifford GM, Snijders PJF, Arslan A, Anh PTH, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao Y-L, Rajkumar R, Ronco G, de Sanjose S, Shin H-R, Sukvirach S, Thomas JO, Meijer CJLM, Mu\u00f1oz N, the IARC HPV Prevalence Surveys Study Group. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119:2677\u201384.","journal-title":"Int J Cancer"},{"issue":"2","key":"6388_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/IGC.0b013e31823c2469","volume":"22","author":"AM Bedoya","year":"2012","unstructured":"Bedoya AM, Gaviria AM, Baena A, Borrero M, Duarte DF, Combita AL, Casta\u00f1o J, Grisales H, S\u00e1nchez GI. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia. Int J Gynecol Cancer. 2012;22(2):303\u201310.","journal-title":"Int J Gynecol Cancer"},{"key":"6388_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/1874357901206010198","volume":"6","author":"PE Gravitt","year":"2012","unstructured":"Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J. 2012;6:198\u2013203.","journal-title":"Open Virol J"},{"key":"6388_CR16","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-12-2635","volume":"72","author":"AF Rositch","year":"2012","unstructured":"Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res. 2012;72:6183\u201390.","journal-title":"Cancer Res"},{"key":"6388_CR17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s10552-010-9598-2","volume":"21","author":"E Lazcano-Ponce","year":"2010","unstructured":"Lazcano-Ponce E, Lorincz AT, Salmer\u00f3n J, Fern\u00e1ndez I, Cruz A, Hernandez P, Mejia I, Hern\u00e1ndez-\u00c1vila M. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican social security program. Cancer Causes Control. 2010;21:1693\u2013700.","journal-title":"Cancer Causes Control"},{"key":"6388_CR18","first-page":"593","volume":"30","author":"E Matos","year":"2003","unstructured":"Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJC, Meijer CJLM, Mu\u00f1oz N, Herrero R. Prevalence of human papillomavirus infection among women in Concordia. Argentina: Sex Transm Dis. 2003;30:593\u20139.","journal-title":"Argentina: Sex Transm Dis"},{"key":"6388_CR19","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-12-2635","volume":"72","author":"AF Rositch","year":"2012","unstructured":"Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res. 2012;72:6183\u201390.","journal-title":"Cancer Res"},{"key":"6388_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ygyno.2012.08.033","volume":"127","author":"ER Bahmanyar","year":"2012","unstructured":"Bahmanyar ER, Paavonen J, Naud P, JJorge S, Chow S-N, Apter D, Kitchener H, Castellsagu\u00e9 X, Teixeira JC, Skinner SR, Jaisamrarn U, Limson GA, Garland SM, Szarewski A, Romanowski B, Aoki F, Schwarz TF, Poppe WAJ, De Carvalho NS, Harper DM, Bosch FX, Raillard A, Descamps D, Struyf F, Lehtinen M, Dubin G. Group FTHPS: prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. 2012;127:440\u201350.","journal-title":"Gynecol Oncol"},{"key":"6388_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-145","volume":"12","author":"E Roura","year":"2012","unstructured":"Roura E, Iftner T, Vidart JA, Kjaer SK, Bosch FX, Mu\u00f1oz N, Palacios S, Rodriguez MSM, Morillo C, Serradell L, Torcel-Pagnon L, Cortes J, Castellsagu\u00e9 X. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis. 2012;12:1\u201313.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6388_CR22","doi-asserted-by":"publisher","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","volume":"11","author":"E Roura","year":"2016","unstructured":"Roura E, Travier N, Waterboer T, de Sanjos\u00e9 S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tj\u00f8nneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Quir\u00f3s JR, S\u00e1nchez MJ, Navarro C, Barricarte A, Larra\u00f1aga N, Ekstr\u00f6m J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagu\u00e9 X. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One. 2016;11(1):e0147029.","journal-title":"PLoS One"},{"issue":"9","key":"6388_CR23","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1111\/j.1349-7006.2010.01642.x","volume":"101","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Hirai Y, Mitsuhashi A, Fujii T, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T. Yoshikawa H; Japan HPV and cervical Cancer (JHACC) study group. Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Sci. 2010;101(9):2065\u201373.","journal-title":"Cancer Sci"},{"issue":"7","key":"6388_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1158\/1055-9965.EPI-11-0284","volume":"20","author":"KS Louie","year":"2011","unstructured":"Louie KS, Castellsague X, de Sanjose S, Herrero R, Meijer CJ, Shah K, Munoz N. Bosch FX; International Agency for Research on Cancer multicenter cervical Cancer study group. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies. Cancer Epidemiol Biomark Prev. 2011;20(7):1379\u201390.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6388_CR25","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","volume":"26","author":"FX Bosch","year":"2008","unstructured":"Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Mu\u00f1oz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26:K1\u2013K16.","journal-title":"Vaccine"},{"key":"6388_CR26","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","volume":"70","author":"H Trottier","year":"2010","unstructured":"Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JCM, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70:8569\u201377.","journal-title":"Cancer Res"},{"key":"6388_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/infdis\/jis660","volume":"207","author":"PE Gravitt","year":"2013","unstructured":"Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, Viscidi RP. Cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis. 2013;207:272\u20138.","journal-title":"J Infect Dis"},{"issue":"10","key":"6388_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025493","volume":"6","author":"A Ciapponi","year":"2011","unstructured":"Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One. 2011;6(10):e25493 Review.","journal-title":"PLoS One"},{"issue":"Suppl 11","key":"6388_CR29","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1016\/j.vaccine.2008.05.043","volume":"26","author":"DM Parkin","year":"2008","unstructured":"Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Pi\u00f1eeros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine. 2008;26(Suppl 11):L1\u201315.","journal-title":"Vaccine"},{"issue":"10","key":"6388_CR30","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359.","journal-title":"Int J Cancer"},{"issue":"7","key":"6388_CR31","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/IGC.0b013e3181f16c5f","volume":"20","author":"J Ting","year":"2010","unstructured":"Ting J, Kruzikas DT, Smith JS. A global review of age-specific and overall prevalence of cervical lesions. Int J Gynecol Cancer. 2010;20(7):1244\u20139 Review.","journal-title":"Int J Gynecol Cancer"},{"key":"6388_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1471-0528.2011.02970.x","volume":"119","author":"R Kelly","year":"2012","unstructured":"Kelly R, Walker P, Kitchener H, Moss S. Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative\/human papillomavirus-positive women with low-grade cytological abnormalities. BJOG. 2012;119:20\u20135.","journal-title":"BJOG"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6388-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:17:55Z","timestamp":1607476675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6388"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6388-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this study was a retrospective confidential analysis of stored databases, no approval from the research and Bioethics Committee was needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1205"}}